Release Date:    Thursday, April 17, 2014
Expiration Date:    Thursday, April 16, 2015

Downloadable slide decks are a great tool for self-study and teaching purposes. They are non-certified resources available to enhance your knowledge.

Review this downloadable slide deck developed by Robert G. Gish, MD covering the most clinically relevant new data reported from Advanced Hepatocellular Carcinoma: Management Strategies for Emerging Targeted Therapies.

Target Audience

This activity is designed for medical oncologists, surgical oncologists, gastroenterologists, hepatologists, pathologists, interventional radiologists, diagnostic radiologists, primary care physicians and other healthcare professionals involved in the treatment of patients with hepatocellular carcinoma (HCC).

Format: Microsoft PowerPoint (.ppt) | File size: 10.7 MB | Date posted: 4/17/2014

Slide Deck Disclaimer

This slide deck in its original and unaltered format is for educational purposes and is current as of April 2014. All materials contained herein reflect the views of the faculty, and not those of AXIS, the CME provider, or the commercial supporter. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should not rely on this information as a substitute for professional medical advice, diagnosis, or treatment. The use of any information provided is solely at your own risk, and readers should verify the prescribing information and all data before treating patients or employing any therapeutic products described in this educational activity.

Usage Rights

This slide deck is provided for educational purposes and individual slides may be used for personal, non-commercial presentations only if the content and references remain unchanged. No part of this slide deck may be published in print or electronically as a promotional or certified educational activity without prior written permission from AXIS. Additional terms may apply. See Terms of Service for details.